Prognostic factors in lymph node metastases of prostatic cancer patients: The size of the metastases but not extranodal extension independently predicts survival

Histopathology

Volumn 53, Issue 4, 2008, Pages 468-475

  Fleischmann, A ^a   Schobinger, S ^a   Markwalder, R ^a   Schumacher, M ^a   Burkhard, F ^a   Thalmann, G N ^a   Studer, U E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Extranodal extension; Metastasis; Prognosis; Prostatectomy; Prostatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; GLEASON SCORE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY;

AGED; COHORT STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 52649092318     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03129.x     Document Type: Article

References (33)

1. Seay TM, Blute ML, Zincke H. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation. J. Urol. 1998 159 357 364.
2. van den Ouden D, Schroder FH. Management of locally advanced prostate cancer. 1. Staging, natural history, and results of radical surgery. World J. Urol. 2000 18 194 203.
3. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001 91 66 73.
4. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J. Urol. 2003 169 849 854.
5. Burkhard FC, Studer UE. The role of lymphadenectomy in prostate cancer. Urol. Oncol. 2004 22 198 202.
6. Di Giorgio A, Botti C, Sammartino P, Mingazzini P, Flammia M, Stipa V. Extracapsular lymphnode metastases in the staging and prognosis of gastric cancer. Int. Surg. 1991 76 218 221.
7. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol. Head Neck Surg. 1996 114 65 70.
8. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 1997 80 2268 2272.
9. Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, van Lanschot JJ. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am. J. Surg. Pathol. 2006 30 171 176.
10. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001 92 3030 3036.
11. Komuta K, Okudaira S, Haraguchi M, Furui J, Kanematsu T. Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis. Colon Rectum 2001 44 1838 1844.
12. Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr. Penile cancer: relation of extent of nodal metastasis to survival. J. Urol. 1987 137 880 882.
13. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am. J. Surg. Pathol. 2005 29 89 95.
14. Griebling TL, Ozkutlu D, See WA, Cohen MB. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. Mod. Pathol. 1997 10 804 809.
15. Cheng L, Pisansky TM, Ramnani DM et al. Extranodal extension in lymph node-positive prostate cancer. Mod. Pathol. 2000 13 113 118.
16. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J. Urol. 2002 168 514 518.
17. Epstein JI, Algaba F, Allsbrook WC Jr. et al. Acinar adenocarcinoma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA eds. World Heath Organisation classification of tumour. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004 162 198.
18. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD. Evaluating the radical prostatectomy specimen, part I. J. Urol. Pathol. 1995 3 355 364.
19. Sobin LH, Wittekind C eds. TNM Atlas, 6th edn. New York: Wiley-Lyss, Inc., 2002.
20. Katz A, Strom EA, Buchholz TA et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J. Clin. Oncol. 2000 18 2817 2827.
21. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000 46 467 474.
22. Neri A, Marrelli D, Roviello F et al. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Ann. Surg. Oncol. 2005 12 246 253.
23. Daneshmand S, Quek ML, Stein JP et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J. Urol. 2004 172 2252 2255.
24. Aus G, Nordenskjold K, Robinson D, Rosell J, Varenhorst E. Prognostic factors and survival in node-positive (N1) prostate cancer - a prospective study based on data from a Swedish population-based cohort. Eur. Urol. 2003 43 627 631.
25. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J. Urol. 2004 172 1840 1844.
26. Cheng L, Bergstralh EJ, Cheville JC et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am. J. Surg. Pathol. 1998 22 1491 1500.
27. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J. Urol. 2002 167 1681 1686.
28. Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur. Urol. 2007 52 29 37.
29. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J. Urol. 1996 156 1969 1971.
30. Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J. Urol. 2004 172 1860 1864.
31. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N. Engl. J. Med. 1999 341 1781 1788.
32. Boorjian SA, Thompson RH, Siddiqui S et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J. Urol. 2007 178 864 871.
33. Epstein JI, Srigley J, Grignon D, Humphrey P. Recommendations for the reporting of prostate carcinoma. Hum. Pathol. 2007 38 1305 1309.